World Journal of Hepatology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Dobrowolska K, Zarębska-Michaluk D, Pawłowska M, Tudrujek-Zdunek M, Lorenc B, Berak H, Janczewska E, Mazur W, Janocha-Litwin J, Klapaczyński J, Sitko M, Dybowska D, Parfieniuk-Kowerda A, Piekarska A, Jaroszewicz J, Flisiak R. Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs. World J Hepatol 2025; 17(6): 105899 [PMID: 40606929 DOI: 10.4254/wjh.v17.i6.105899]
URL:	https://www.wjgnet.com/1948-5182/full/v17/i6/105899.htm

For:

Dobrowolska K, Zarębska-Michaluk D, Pawłowska M, Tudrujek-Zdunek M, Lorenc B, Berak H, Janczewska E, Mazur W, Janocha-Litwin J, Klapaczyński J, Sitko M, Dybowska D, Parfieniuk-Kowerda A, Piekarska A, Jaroszewicz J, Flisiak R. Sex-related differences in patients with chronic hepatitis C infection treated with direct-acting antiviral drugs. World J Hepatol 2025; 17(6): 105899 [PMID: 40606929 DOI: 10.4254/wjh.v17.i6.105899]

URL:

https://www.wjgnet.com/1948-5182/full/v17/i6/105899.htm

(69) (76) (0) (0) (0) (2078) (8)

Number	Citing Articles
1	Ashish Goyal, Scott J Cotler, Gail V Matthews, Kimberly Page, Tatyana Kushner, Ohad Etzion, Marianne Martinello, Harel Dahari. Modeling Predicts Direct-Acting Antiviral Therapy for 5-Weeks May Cure Recent or Chronic Hepatitis C Infection Among People With Undetectable Viral RNA by Day 7. The Journal of Infectious Diseases 2026; doi: 10.1093/infdis/jiag260
2	Alessio Aghemo, Alessia Ciancio, Ernesto Claar, Nicola Coppola, Alessandra Mangia, Marco Riglietta, Massimo Puoti. Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir–Velpatasvir. Viruses 2026; 18(8) doi: 10.3390/v18080854
3	Nikolaos Georgiadis, Christina Seitopoulou, Maria Kimouli, Theodoros N. Sergentanis, Apostolos Beloukas, Georgina Tzanakaki. HBV and HCV Burden in a Greek Hospital Population (2018–2024): Trends and Correlates of HBsAg and Anti-HCV Positivity. Pathogens 2026; 15(3) doi: 10.3390/pathogens15030342
4	Eyad Gadour. Gender disparities in hepatitis C treatment: A call for tailored approaches. World Journal of Hepatology 2025; 17(9): 110128 doi: 10.4254/wjh.v17.i9.110128 Abstract(149) \| Core Tip(147) \| Full Article(HTML)(332) \| Full Article (PDF)-341K(61) \| Full Article with Cover (PDF)-677K(42) \| Full Article (XML)-26K(53) \| Audio-470K(12) \| Peer-Review Report-225K(68) \| Answering Reviewers-55K(70) \| Times Cited (0) \| Total Visits (488) \| Open
5	Michał Brzdęk, Dorota Zarębska-Michaluk, Olga Tronina, Łukasz Laurans, Ewa Janczewska, Dorota Dybowska, Anna Parfieniuk-Kowerda, Magdalena Tudrujek-Zdunek, Jolanta Białkowska-Warzecha, Justyna Janocha-Litwin, Robert Flisiak. Treatment with Direct-Acting Antivirals in Patients with HCV Infection After Liver Transplantation. Journal of Clinical Medicine 2026; 15(1) doi: 10.3390/jcm15010346
6	Nora Cazzagon, Martina Gambato, Maurizia Rossana Brunetto, Erica Villa, Patrizia Burra, Annarosa Floreani. Sex Hormones and the Liver: Implications for Disease Progression and Hormonal Therapy. Liver International 2026; 46(2) doi: 10.1111/liv.70509
7	Fabienne Marcellin, Clémence Ramier, Cécile Brouard, Vincent Di Beo, Yoann Allier, Abbas Mourad, Morgane Bureau‐Stoltmann, Philippe Sogni, Sylvie Deuffic‐Burban, Patrizia Carrieri, Benjamin Rolland, Marc Bourliere, Camelia Protopopescu. Sex Disparities in Hepatitis C Treatment Initiation: Role of Universal Access to DAA in France (ANRS FANTASIO 2). Liver International 2026; 46(10) doi: 10.1111/liv.70884